Deep Learning Market in Drug Discovery and Diagnostics Research Report 2025-2035, Profiles of Aegicare, Aiforia, Ardigen, Berg, Google, Huawei, Merative, Nference, Nvidia, Owkin, Phenomic AI, Pixel AI - ResearchAndMarkets.com
DUBLIN--( BUSINESS WIRE)--The "Deep Learning Market in Drug Discovery and Diagnostics - Industry Trends and Global Forecasts to 2035: By Therapeutic Areas and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.
The global deep learning market in drug discovery and diagnostic is estimated to grow from USD 3.6 billion in 2025, to USD 34.5 billion by 2035, at a CAGR of 21.9% during the forecast period, till 2035.
Deep Learning Market in Drug Discovery and Diagnostics: Growth and Trends
Deep learning is a complex machine learning algorithm that has the ability to process a large amount of data using neural networks. Over the past few years, deep learning has evolved as an excellent computational resource, as a result of which, various technology developers are shifting their focus towards this industry. Intelligent machines backed by relevant deep learning models are already producing significant results across various segments of the industry.
The potential applications of the technique in feature extraction, medical imaging, diagnostics, and drug discovery and development have significantly assisted the healthcare and life sciences domain. Additionally, recent advancements in the deep learning market have demonstrated its potential in other healthcare-associated segments, such as molecular profiling, AI in medical imaging, data analysis and virtual screening. Owing to high investments, rising adoption of deep learning technologies and the ongoing pace of innovation, deep learning market in healthcare and drug discovery is projected to witness significant growth in the coming years.
Deep Learning Market in Drug Discovery and Diagnostics: Key Segments
Oncological Disorders Segment Accounts for the Largest Share of the Deep Learning Market for Drug Discovery and Diagnostics
Based on the therapeutic area, the market is segmented into oncological disorders, infectious diseases, neurological disorders, immunological disorders, endocrine disorders, cardiovascular disorders, respiratory disorders, eye disorders, musculoskeletal disorders, inflammatory disorders and other disorders. While oncological disorders account for a relatively higher market share, it is worth highlighting that the musculoskeletal disorders segment is expected to witness substantial market growth in the coming years.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the world. Majority share is expected to be captured by technology developers based in North America and Europe. It is worth highlighting that, over the years, the market for Asia-pacific is expected to grow at a higher CAGR.
Deep Learning Market in Drug Discovery and Diagnostics: Key Insights
Reasons to Buy this Report
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
Players in the Deep Learning Market in Drug Discovery and Diagnostics, Profiled in the Report Include:
Report Segmentation
Therapeutic Areas
Key Geographical Regions
Additional Benefits
For more information about this report visit https://www.researchandmarkets.com/r/cnjlbb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.